Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP235677.RAGYCPi-bXfTfOlzwN3TVb6Sj3L3p62aOI5XpOEgID3jc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP235677.RAGYCPi-bXfTfOlzwN3TVb6Sj3L3p62aOI5XpOEgID3jc130_assertion type Assertion NP235677.RAGYCPi-bXfTfOlzwN3TVb6Sj3L3p62aOI5XpOEgID3jc130_head.
- NP235677.RAGYCPi-bXfTfOlzwN3TVb6Sj3L3p62aOI5XpOEgID3jc130_assertion description "[Patients with ALK gene rearrangements (OR = 5.50; 95% CI = 1.76, 17.18; P = .003) and patients with EGFR mutations (OR = 5.17; 95% CI = 1.63, 16.43; P = .006) were predisposed to liver metastasis compared to the triple negative cohort.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP235677.RAGYCPi-bXfTfOlzwN3TVb6Sj3L3p62aOI5XpOEgID3jc130_provenance.
- NP235677.RAGYCPi-bXfTfOlzwN3TVb6Sj3L3p62aOI5XpOEgID3jc130_assertion evidence source_evidence_literature NP235677.RAGYCPi-bXfTfOlzwN3TVb6Sj3L3p62aOI5XpOEgID3jc130_provenance.
- NP235677.RAGYCPi-bXfTfOlzwN3TVb6Sj3L3p62aOI5XpOEgID3jc130_assertion SIO_000772 22282022 NP235677.RAGYCPi-bXfTfOlzwN3TVb6Sj3L3p62aOI5XpOEgID3jc130_provenance.
- NP235677.RAGYCPi-bXfTfOlzwN3TVb6Sj3L3p62aOI5XpOEgID3jc130_assertion wasDerivedFrom befree-20150227 NP235677.RAGYCPi-bXfTfOlzwN3TVb6Sj3L3p62aOI5XpOEgID3jc130_provenance.
- NP235677.RAGYCPi-bXfTfOlzwN3TVb6Sj3L3p62aOI5XpOEgID3jc130_assertion wasGeneratedBy ECO_0000203 NP235677.RAGYCPi-bXfTfOlzwN3TVb6Sj3L3p62aOI5XpOEgID3jc130_provenance.